tm logo

Monitor this mark

View On USPTO

INFLUENZA VACCINE FLUCELVAX QUADRIVALENT
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 28 Jul 2023

Last Applicant/ Owned by

Seqirus UK Limited

Point, 29 Market Street

Maidenhead, Berkshire

GB

SL6 8AA

Serial Number

87135582 filed on 11th Aug 2016

Registration Number

5170554 registered on 28th Mar 2017

in the Principal Register

Correspondent Address

Nancy Sabarra

Nancy Sabarra

151 W 42nd St., 17th Floor

New York NY 10036

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

INFLUENZA VACCINE FLUCELVAX QUADRIVALENT

Influenza vaccines for human use

Classification Information

Class [005]
Pharmaceutical Products

Influenza vaccines for human use

First Use Date in General

27th Jul 2016

First Use Date in Commerce

27th Jul 2016

Specimens

INFLUENZA VACCINE FLUCELVAX QUADRIVALENT specimenINFLUENZA VACCINE FLUCELVAX QUADRIVALENT specimen

Mark Details

Serial Number

No 87135582

Mark Type

No Service/Collective Mark

Attorney Docket Number

No SEQI 1508757

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.01.05 -

Stars with seven or more points

01.01.11 -

Incomplete stars

26.01.31 -

Five or more circles

Legal History

Show more

Status DateAction Taken
28th Jul 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
28th Jul 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
28th Jul 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01st Feb 2023TEAS SECTION 8 & 15 RECEIVED
28th Mar 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05th Apr 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
28th Mar 2017REGISTERED-PRINCIPAL REGISTER
31st Jan 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
10th Jan 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10th Jan 2017PUBLISHED FOR OPPOSITION